Literature DB >> 17601816

Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice.

Luis G Bermúdez-Humarán1, Sébastien Nouaille, Vladimir Zilberfarb, Gérard Corthier, Alexandra Gruss, Philippe Langella, Tarik Issad.   

Abstract

Leptin is an adipocyte-derived pleiotropic hormone that modulates a large number of physiological functions, including control of body weight and regulation of the immune system. In this work, we show that a recombinant strain of the food-grade lactic acid bacterium Lactococcus lactis (LL-lep) can produce and efficiently secrete human leptin. The secreted leptin is a fully biologically active hormone, as demonstrated by its capacity to stimulate a STAT3 reporter gene in HEK293 cells transfected with the Ob-Rb leptin receptor. The immunomodulatory activity of leptin-secreting L. lactis was evaluated in vivo by coexpression with the human papillomavirus type 16 E7 protein. In C57BL/6 mice immunized intranasally with a recombinant L. lactis strain coproducing leptin and E7 antigen, the adaptive immune response was significantly higher than in mice immunized with recombinant L. lactis producing only E7 antigen, demonstrating adjuvanticity of leptin. We then analyzed the effects of intranasally administered LL-lep in obese ob/ob mice. We observed that daily administration of LL-lep to these mice significantly reduced body weight gain and food intake. These results demonstrate that leptin can be produced and secreted in an active form by L. lactis and that leptin-producing L. lactis regulates in vivo antigen-specific immune responses, as well as body weight and food consumption.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17601816      PMCID: PMC1950963          DOI: 10.1128/AEM.00295-07

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  70 in total

1.  A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors.

Authors:  Luis G Bermúdez-Humarán; Naima G Cortes-Perez; François Lefèvre; Valeria Guimarães; Sylvie Rabot; Juan M Alcocer-Gonzalez; Jean-Jacques Gratadoux; Cristina Rodriguez-Padilla; Reyes S Tamez-Guerra; Gérard Corthier; Alexandra Gruss; Philippe Langella
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

2.  Nasal administration of the calcium channel blocker diltiazem decreases food intake and attenuates weight gain in rats.

Authors:  Ahmed Amer; Timothy J Maher
Journal:  Pharmacol Biochem Behav       Date:  2005-10-07       Impact factor: 3.533

3.  A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes.

Authors:  R W Tindle; G J Fernando; J C Sterling; I H Frazer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

4.  Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells.

Authors:  M C Feltkamp; H L Smits; M P Vierboom; R P Minnaar; B M de Jongh; J W Drijfhout; J ter Schegget; C J Melief; W M Kast
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

5.  Role of olfaction in starch and oil preference.

Authors:  I Ramirez
Journal:  Am J Physiol       Date:  1993-12

6.  Brain uptake of intranasally applied radioiodinated leptin in Wistar rats.

Authors:  Stephanie Fliedner; Carla Schulz; Hendrik Lehnert
Journal:  Endocrinology       Date:  2006-02-09       Impact factor: 4.736

7.  Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis.

Authors:  P Langella; Y Le Loir; S D Ehrlich; A Gruss
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

8.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

9.  Effects of the obese gene product on body weight regulation in ob/ob mice.

Authors:  M A Pelleymounter; M J Cullen; M B Baker; R Hecht; D Winters; T Boone; F Collins
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

Review 10.  Intracellular signalling pathways activated by leptin.

Authors:  Gema Frühbeck
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

View more
  13 in total

1.  Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment.

Authors:  Jacques Amar; Chantal Chabo; Aurélie Waget; Pascale Klopp; Christelle Vachoux; Luis G Bermúdez-Humarán; Natalia Smirnova; Mathieu Bergé; Thierry Sulpice; Sampo Lahtinen; Arthur Ouwehand; Philippe Langella; Nina Rautonen; Philippe J Sansonetti; Rémy Burcelin
Journal:  EMBO Mol Med       Date:  2011-08-03       Impact factor: 12.137

Review 2.  Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines.

Authors:  Luis G Bermúdez-Humarán; Pascale Kharrat; Jean-Marc Chatel; Philippe Langella
Journal:  Microb Cell Fact       Date:  2011-08-30       Impact factor: 5.328

Review 3.  Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes.

Authors:  Olivia Cano-Garrido; Joaquin Seras-Franzoso; Elena Garcia-Fruitós
Journal:  Microb Cell Fact       Date:  2015-09-16       Impact factor: 5.328

Review 4.  Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes case.

Authors:  Sofie Robert; Lothar Steidler
Journal:  Microb Cell Fact       Date:  2014-08-29       Impact factor: 5.328

Review 5.  Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.

Authors:  Rodrigo D De Oliveira Carvalho; Fillipe L R do Carmo; Alberto de Oliveira Junior; Philippe Langella; Jean-Marc Chatel; Luis G Bermúdez-Humarán; Vasco Azevedo; Marcela S de Azevedo
Journal:  Front Microbiol       Date:  2017-05-09       Impact factor: 5.640

Review 6.  Vector Development Timeline for Mucosal Vaccination and Treatment of Disease Using Lactococcus lactis and Design Approaches of Next Generation Food Grade Plasmids.

Authors:  Camila Prosperi de Castro; Mariana M Drumond; Viviane L Batista; Amanda Nunes; Pamela Mancha-Agresti; Vasco Azevedo
Journal:  Front Microbiol       Date:  2018-08-14       Impact factor: 5.640

7.  Oral delivery of pancreatitis-associated protein by Lactococcus lactis displays protective effects in dinitro-benzenesulfonic-acid-induced colitis model and is able to modulate the composition of the microbiota.

Authors:  Natalia M Breyner; Priscilla Bagano Vilas Boas; Gabriel Fernandes; Rodrigo D de Carvalho; Tatiana Rochat; Marie-Laure Michel; Florian Chain; Harry Sokol; Marcela de Azevedo; Anderson Myioshi; Vasco A Azevedo; Philippe Langella; Luis G Bermúdez-Humarán; Jean-Marc Chatel
Journal:  Environ Microbiol       Date:  2019-09-10       Impact factor: 5.491

Review 8.  Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease.

Authors:  Rebeca Martín; Sylvie Miquel; Jonathan Ulmer; Noura Kechaou; Philippe Langella; Luis G Bermúdez-Humarán
Journal:  Microb Cell Fact       Date:  2013-07-23       Impact factor: 5.328

Review 9.  Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications.

Authors:  C Michon; P Langella; V G H Eijsink; G Mathiesen; J M Chatel
Journal:  Microb Cell Fact       Date:  2016-05-03       Impact factor: 5.328

10.  Exploiting Prophage-Mediated Lysis for Biotherapeutic Release by Lactobacillus reuteri.

Authors:  Laura M Alexander; Jee-Hwan Oh; Donald S Stapleton; Kathryn L Schueler; Mark P Keller; Alan D Attie; Jan-Peter van Pijkeren
Journal:  Appl Environ Microbiol       Date:  2019-05-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.